Search Results
Search for other papers by Valeria Hirschler in
Google Scholar
PubMed
Search for other papers by Claudia Molinari in
Google Scholar
PubMed
Search for other papers by Silvia Lapertosa in
Google Scholar
PubMed
Search for other papers by Gustavo Maccallini in
Google Scholar
PubMed
Search for other papers by Claudio D Gonzalez in
Google Scholar
PubMed
.22 Non-HDL-C (mg/dL) 101.09 ± 25.25 105 ± 25.44 103.02 ± 25.41 a P < 0.05 and b P < 0.01. BP, blood pressure; TG, triglycerides; z-BMI, BMI z-score. The prevalence of OW/OB was 32% (405) and central OB was 24.5 % (310
Search for other papers by Heike Hoyer-Kuhn in
Google Scholar
PubMed
Search for other papers by Angela Huebner in
Google Scholar
PubMed
Search for other papers by Anette Richter-Unruh in
Google Scholar
PubMed
Search for other papers by Markus Bettendorf in
Google Scholar
PubMed
Search for other papers by Tilman Rohrer in
Google Scholar
PubMed
Search for other papers by Klaus Kapelari in
Google Scholar
PubMed
St.Anna Kinderspital, Medical University of Vienna, Vienna, Austria
Search for other papers by Stefan Riedl in
Google Scholar
PubMed
Search for other papers by Klaus Mohnike in
Google Scholar
PubMed
Search for other papers by Helmuth-Günther Dörr in
Google Scholar
PubMed
Search for other papers by Friedrich-Wilhelm Roehl in
Google Scholar
PubMed
Search for other papers by Katharina Fink in
Google Scholar
PubMed
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
of 15 mg/m 2 BSA were assessed (height, weight, BMI, and blood pressure). Participating centers were defined as big and small centers to assess the influence of the center size to treatment regimens. Periods of treatment (before or after 2005
Search for other papers by Raja Padidela in
Google Scholar
PubMed
Search for other papers by Moira S Cheung in
Google Scholar
PubMed
Search for other papers by Vrinda Saraff in
Google Scholar
PubMed
Search for other papers by Poonam Dharmaraj in
Google Scholar
PubMed
monitor development and progression of nephrocalcinosis. On an annual basis, blood pressure should be checked. A clinical assessment of skeletal deformity, including craniosynostosis when age appropriate, should also be made at every clinic visit and, if
Department of Pediatrics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Reproduction & Development Research Institute, de Boelelaan, Amsterdam, The Netherlands
Search for other papers by Britt J van Keulen in
Google Scholar
PubMed
Department of Pediatrics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Reproduction & Development Research Institute, de Boelelaan, Amsterdam, The Netherlands
Search for other papers by Michelle Romijn in
Google Scholar
PubMed
Search for other papers by Bibian van der Voorn in
Google Scholar
PubMed
Search for other papers by Marita de Waard in
Google Scholar
PubMed
Search for other papers by Michaela F Hartmann in
Google Scholar
PubMed
Search for other papers by Johannes B van Goudoever in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Search for other papers by Joost Rotteveel in
Google Scholar
PubMed
Department of Pediatrics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Reproduction & Development Research Institute, de Boelelaan, Amsterdam, The Netherlands
Search for other papers by Martijn J J Finken in
Google Scholar
PubMed
essential for blood pressure maintenance ( 7 ) and has been presumed to play a role in the dampening of the immune response ( 8 ). During their first weeks of life, many preterm infants fail to mount an adequate cortisol response for the degree of stress or